Literature DB >> 24203060

Glucose-stimulated oxidative stress in mononuclear cells is related to pancreatic β-cell dysfunction in polycystic ovary syndrome.

Steven K Malin1, John P Kirwan, Chang Ling Sia, Frank González.   

Abstract

CONTEXT: Oxidative stress induced by reactive oxygen species (ROS) is involved in the development of pancreatic β-cell dysfunction.
OBJECTIVE: We determined the relationship between mononuclear cell (MNC)-derived ROS generation and p47phox protein content in response to glucose ingestion and β-cell function in women with polycystic ovary syndrome (PCOS).
DESIGN: This was a cross-sectional study.
SETTING: This study was conducted at an academic medical center. PARTICIPANTS: Twenty-nine normoglycemic women with PCOS (13 lean, 16 obese) and 25 ovulatory controls (16 lean, 9 obese) underwent a 3-h 75-g oral glucose tolerance test (OGTT). MAIN OUTCOME VARIABLES: Pancreatic β-cell function was calculated as glucose-stimulated insulin secretion (insulin/glucose area under the curve0-30 min; GSIS)×Matsuda index-derived insulin sensitivity (ISOGTT). ROS generation was measured by chemiluminescence, and p47phox protein was quantified by Western blotting in MNC isolated from blood samples obtained at 0 and 2 hours of the OGTT.
RESULTS: Compared with controls, women with PCOS exhibited a higher percent change from baseline in ROS generation and p47phox protein in conjunction with greater GSIS and a tendency toward lower β-cell function. Lean women with PCOS exhibited a greater percent change from baseline in ROS generation and p47phox protein yet had similar GSIS responses compared with lean controls despite having lower ISOGTT. For the combined groups, β-cell function was inversely related to ROS generation and p47phox protein. GSIS was directly related to body mass index, central obesity, and circulating androgens.
CONCLUSION: In normoglycemic women, obesity plays a role in exaggerating GSIS. However, MNC-derived oxidative stress is independent of obesity and may contribute to the decline in β-cell function in women with PCOS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24203060      PMCID: PMC3879676          DOI: 10.1210/jc.2013-3177

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  40 in total

1.  Measurement of reactive oxygen species in whole blood and mononuclear cells using chemiluminescence.

Authors:  K Thusu; E Abdel-Rahman; P Dandona
Journal:  Methods Mol Biol       Date:  1998

2.  Assessment of insulin sensitivity from measurements in the fasting state and during an oral glucose tolerance test in polycystic ovary syndrome and menopausal patients.

Authors:  Mario Ciampelli; Fulvio Leoni; Francesco Cucinelli; Salvatore Mancuso; Simona Panunzi; Andrea De Gaetano; Antonio Lanzone
Journal:  J Clin Endocrinol Metab       Date:  2004-12-14       Impact factor: 5.958

3.  Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome.

Authors:  A Dunaif; D T Finegood
Journal:  J Clin Endocrinol Metab       Date:  1996-03       Impact factor: 5.958

Review 4.  Insulin action in the normal and polycystic ovary.

Authors:  S Franks; C Gilling-Smith; H Watson; D Willis
Journal:  Endocrinol Metab Clin North Am       Date:  1999-06       Impact factor: 4.741

5.  Tumor necrosis factor-alpha stimulates proliferation of rat ovarian theca-interstitial cells.

Authors:  R Z Spaczynski; A Arici; A J Duleba
Journal:  Biol Reprod       Date:  1999-10       Impact factor: 4.285

6.  The use of anthropometric and dual-energy X-ray absorptiometry (DXA) measures to estimate total abdominal and abdominal visceral fat in men and women.

Authors:  J L Clasey; C Bouchard; C D Teates; J E Riblett; M O Thorner; M L Hartman; A Weltman
Journal:  Obes Res       Date:  1999-05

7.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Authors:  M Matsuda; R A DeFronzo
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

8.  Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome.

Authors:  M Ciampelli; A M Fulghesu; F Cucinelli; V Pavone; E Ronsisvalle; M Guido; A Caruso; A Lanzone
Journal:  Metabolism       Date:  1999-02       Impact factor: 8.694

9.  Meal-generated oxidative stress in type 2 diabetic patients.

Authors:  A Ceriello; N Bortolotti; E Motz; A Crescentini; S Lizzio; A Russo; L Tonutti; C Taboga
Journal:  Diabetes Care       Date:  1998-09       Impact factor: 19.112

10.  Heterogeneity in beta cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome.

Authors:  M Ciampelli; A M Fulghesu; F Cucinelli; V Pavone; A Caruso; S Mancuso; A Lanzone
Journal:  Hum Reprod       Date:  1997-09       Impact factor: 6.918

View more
  12 in total

1.  Plasma total oxidant and antioxidant status after oral glucose tolerance and mixed meal tests in patients with polycystic ovary syndrome.

Authors:  Zehra Kucukaydın; Cevdet Duran; Mustafa Basaran; Fatos Camlica; Sami Said Erdem; Ahmet Basaran; Orkide Kutlu; Ferda Sevimli Burnik; Halis Elmas; Mustafa Sait Gonen
Journal:  J Endocrinol Invest       Date:  2016-06-14       Impact factor: 4.256

2.  Pancreatic β-cell dysfunction in polycystic ovary syndrome: role of hyperglycemia-induced nuclear factor-κB activation and systemic inflammation.

Authors:  Steven K Malin; John P Kirwan; Chang Ling Sia; Frank González
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-02-24       Impact factor: 4.310

3.  Uncoupling protein-2 mediates the protective action of berberine against oxidative stress in rat insulinoma INS-1E cells and in diabetic mouse islets.

Authors:  Limei Liu; Jian Liu; Yuansheng Gao; Xiaoxing Yu; Gang Xu; Yu Huang
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

Review 4.  Polycystic ovary syndrome as a paradigm for prehypertension, prediabetes, and preobesity.

Authors:  Manuel Luque-Ramírez; Héctor F Escobar-Morreale
Journal:  Curr Hypertens Rep       Date:  2014-12       Impact factor: 5.369

5.  Age increases MCP-1 level in association with bariatric surgery operating time and metabolic risk severity.

Authors:  S K Malin; J L Kaplan; L Meng; J C Garmey; J L Kirby; A M Taylor; P T Hallowell; C A McNamara
Journal:  Obes Sci Pract       Date:  2017-04-26

6.  Association of Androgen Excess with Glucose Intolerance in Women with Polycystic Ovary Syndrome.

Authors:  Bingjie Zhang; Jing Wang; Shanmei Shen; Jiayi Liu; Jie Sun; Tianwei Gu; Xiao Ye; Dalong Zhu; Yan Bi
Journal:  Biomed Res Int       Date:  2018-03-08       Impact factor: 3.411

Review 7.  Polycystic ovary syndrome and mitochondrial dysfunction.

Authors:  Jingshun Zhang; Yigang Bao; Xu Zhou; Lianwen Zheng
Journal:  Reprod Biol Endocrinol       Date:  2019-08-16       Impact factor: 5.211

Review 8.  Pathophysiologic mechanisms of obesity- and chronic inflammation-related genes in etiology of polycystic ovary syndrome.

Authors:  Zahra Shaaban; Arezoo Khoradmehr; Amir Amiri-Yekta; Mohammad Reza Jafarzadeh Shirazi; Amin Tamadon
Journal:  Iran J Basic Med Sci       Date:  2019-12       Impact factor: 2.699

9.  RIG-I inhibits pancreatic β cell proliferation through competitive binding of activated Src.

Authors:  Yi Pan; GuangMing Li; HengGao Zhong; MeiJuan Chen; TingTing Chen; LiLi Gao; HuiWen Wu; Jun Guo
Journal:  Sci Rep       Date:  2016-06-28       Impact factor: 4.379

10.  Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies.

Authors:  Miguel A Sanchez-Garrido; Manuel Tena-Sempere
Journal:  Mol Metab       Date:  2020-02-05       Impact factor: 7.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.